Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Altimmune Inc (NASDAQ:ALT)

2.17
Delayed Data
As of Aug 16
 +0.08 / +3.83%
Today’s Change
2.04
Today|||52-Week Range
14.70
-43.50%
Year-to-Date
No recent news for Altimmune Inc.

Today’s Trading

Previous close2.09
Today’s open2.11
Day’s range2.09 - 2.22
Volume16,762
Average volume (3 months)76,888
Market cap$32.2M
Dividend yield--
Data as of 4:00pm ET, 08/16/2017

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)-50.85%
P/E ratio0.7
Price/Sales40.80
Price/Book0.73

Competitors

 Today’s
change
Today’s
% change
MTEMMolecular Templates ...+0.18+3.60%
ALPNAlpine Immune Scienc...-0.07-0.84%
CSBRChampions Oncology I...-0.01-0.43%
APOPCellect Biotechnolog...-0.13-2.02%
Data as of 3:59pm ET, 08/16/2017

Financials

Last reporting dateAugust 5, 2015
EPS forecast (this quarter)-$0.20
Annual revenue (last year)$5.2M
Annual profit (last year)$193.9M
Net profit margin3,706.44%

Profile

Sector
Commercial Services
Industry
Miscellaneous Commercial Services
President, Chief Executive Officer &
Director
William Enright
CFO, Secretary &
EVP-Corporate Development
Elizabeth Adkins Czerepak
Corporate headquarters
Gaithersburg, Maryland

Forecasts